Previous 10 | Next 10 |
2023-08-15 15:55:06 ET Elite Pharmaceuticals, Inc. (ELTP) Q1 2024 Results Conference Call August 15, 2023 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Presentation Operator Good morning, ladies and gentlemen, a...
Conference Call Scheduled for Tuesday, August 15 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / August 14, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic pr...
Financials for First Quarter Fiscal Year 2024 Ended June 30, 2023 will be released on August 14, 2023 NORTHVALE, NJ / ACCESSWIRE / August 9, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, annou...
2023-06-30 14:47:06 ET Elite Pharmaceuticals, Inc. (ELTP) Q4 2023 Earnings Conference Call June 30, 2023 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Conference Call Participants Presentation Operator G...
Conference Call Scheduled for Friday, June 30 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year ended Ma...
Financials for Fiscal Year 2023 Ended March 31, 2023 will be released on June 29, 2023 NORTHVALE, NJ / ACCESSWIRE / June 22, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that ...
2023-05-03 06:18:30 ET Specialty pharmaceutical company, Elite Pharmaceuticals ( OTCQB:ELTP ) appoints Mark Pellegrino as its CFO, effective May 1, 2023. Pellegrino joins Elite with more than 30 years of experience in financial and operational leadership, primarily in the...
NORTHVALE, NJ / ACCESSWIRE / May 3, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, today announced the appointment of Mark Pellegrino as its Chief Financial Officer (CFO), effecti...
2023-04-20 06:47:53 ET Elite Pharmaceuticals ( OTCQB:ELTP ) filed an application to the U.S. Food and Drug Administration (FDA) seeking approval for an undisclosed generic drug in a class of medicines called antimetabolites. The company said that IQVIA reported annual sales for th...
NORTHVALE, NJ / ACCESSWIRE / April 20, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administrati...
News, Short Squeeze, Breakout and More Instantly...
Elite Pharmaceuticals Inc. Company Name:
ELTP Stock Symbol:
OTCMKTS Market:
Elite Pharmaceuticals Inc. Website:
Financials for Fiscal Year 2024 Ended March 31, 2024 will be released on July 1, 2024 Northvale, New Jersey--(Newsfile Corp. - June 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced to...